As evidence is fairly clear to recommend additional therapies for those with osteoporotic-range bone density, there is less evidence to guide recommendations for adding medications when the bone density falls into a low or "osteopenic" range.
Nanjengoko ubungqina bokucebisa ngonyango olongeziweyo lwabo banobunzima bamathambo obukuluhlu lwamathambo abuthathaka bucacile, buncinane kakhulu ubungqina obukhokelela kwiingcebiso ngokongeza amayeza xa ubunzima bamathambo busihla okanye busiba kuluhlu lokuba “buthathaka".